Applikon Bio provides bioprocess equipment and automation solutions for biotechnology research and production

Applikon Bio

Medical Equipment Manufacturing

Getinge

Applikon Biotechnology | 10,671 followers on LinkedIn. Applikon Biotechnology, part of Getinge since January 2020, is a world leader in developing, manufacturing and supplying bioreactor systems for both research and production use. With the stability that Applikon has shown you can rest assured of dependable service and support in the future. Starting in 1973 Applikon has grown from a small sized company supplying laboratory instrumentation to a dynamic worldwide enterprise capable of supplying a broad and diverse line of bioreactor systems.

Director Product Marketing

Timo Keijzer

Managing CFP's, Production startup, no nonsense production and solution driven flow chain. Continues improvement, follow the dots, synergy of people…

Rizah Robin

Scientific Instruments,Biotechnology Equipment and R&D Solutions 法比奥 卡驰拓.-科学仪器专家

Fabio Cacchiata

Gemeenteraadslid GroenLinks Rijswijk & Customer service representative Getinge Applikon

Lara Oude Alink

Applikon Biotechnology

The time has come to say goodbye to our social media channels. We are all wishing you a happy holiday season and are looking forward to welcome you again on our Getinge social media channels in 2022! #hellogoodbye #socialmedia

Domain Not Resolving

SSL by Default

HSTS

Mobile Non Scaleable Content

ASP.NET

ASP.NET 4.0

CPanel

Smart App Banner

Sectigo SSL

Sales and Support

Chris Morgan

Howard Weber

Steve Hey

Operations

Vickie Sanchez

Engineering

Austen Smith

Honesto Manzano

Finance and Administration

Jacobs Marshall Jr

Jaap Oostra

CTO, Co-Owner & Founder

Acquired Computer Companies

European Union (EU) Companies that Exited (Top 10K)

Closed Europe, Middle East, and Africa (EMEA) Health Care Companies

Closed Europe, Middle East, and Africa (EMEA) Companies (Top 10K)

Applikon Biotechnology is a world leader in developing and supplying advanced bioreactor systems from laboratory scale to production scale. We are the only company that can take a customer from the initial screening stage up to full-scale production using the same platform. This minimizes scale-up risks and guarantees the shortest time to market for our customers' new product development.

Applikon is known for bringing new technologies to the market. These new technologies offer advantages in process efficiency for research and development as well as pilot plant and production scale processes.

As a focused medium sized company we live by our motto "A Step Ahead" to differentiate ourselves from other suppliers. Our focus on developing bioreactor systems only, allows us to produce state-of-the-art equipment. This has resulted in a steady growth to the top position of the worldwide laboratory bioreactor market. The basis for our new product development lies in our strong cooperation with leading international universities and institutes.

As a privately owned company our focus is not on short-term shareholders value but on building a healthy company by supplying the best product offering for our customers now and in the long-term future. This is the basis of many long-term relations with our clients all over the world.

All our efforts are focused on supplying the best solution for our clients in the biotech and pharmaceutical industry. Validation and documentation is a vital part of our development procedures and this is extended throughout our whole company.

Applikon Biotechnology is unique in the mini and micro bioreactor range. No other company can offer a complete solution on this very small scale. We develop systems on a small scale that generate results that can be scaled to production scale. At the moment there are thousands of Applikon bioreactors used in the world from small scale R&D up to full scale cGMP production.

Computer and Software Products and Electrical and Scientific Products

Delft

Zuid-Holland

The Netherlands

Europe

Global Bioreactors Market Forecast Report 2024-2035 with Key Players Profiles of Applikon Biotechnology, Bionet ...

Next-gen Biomanufacturing Market Size to Reach US$39.4 Billion by 2032

Mini Bioreactor Market Strategic Assessment with Leading Players- Bioengineering AG, Infors HT, Applikon Biotechnology & Solaris

Applikon Biotechnology offers bioreactor systems that range from laboratory scale to production scale, designed for various bioprocessing applications.

These systems are used to monitor and control bioprocesses, ensuring optimal conditions for biological reactions.

Disposable bioreactors that eliminate the need for cleaning and sterilization, suitable for small-scale production and research.

Software tools for data acquisition, process control, and analysis in bioprocessing applications.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 18, 2024 2:59 PM	2cf595cf
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 18, 2024 2:59 PM	b6e36961
crunchbase trigger	general	Nov 18, 2024 2:59 PM	e85a65a1
crunchbase profile	general	Nov 19, 2024 3:46 AM	f4156593
li profile	general	Nov 18, 2024 2:59 PM	2ae3e992
translate crunchbase fundingrounds	general	Nov 19, 2024 4:12 AM	3ee1cdd9
peers	general	Nov 18, 2024 2:59 PM	3db191ee
news basic	general	Nov 18, 2024 2:59 PM	e066e0b7
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:APPLIKONBIO

Applikon Bio